Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure.
Nishikawa T, Higaki A, Kurokawa K, Yoshimoto K, Horie R, Nakao Y, Fujisawa T, Miyazaki S, Akazawa Y, Miyoshi T, Kawakami H, Higashi H, Tamaki S, Nishimura K, Inoue K, Ikeda S, Yamaguchi O.
Nishikawa T, et al. Among authors: higashi h.
In Vivo. 2025 Jan-Feb;39(1):375-380. doi: 10.21873/invivo.13838.
In Vivo. 2025.
PMID: 39740918